Bays H - Search Results

1

Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group.

Stein EA, Davidson MH, Dobs AS, Schrott H, Dujovne CA, Bays H, Weiss SR, Melino MR, Stepanavage ME, Mitchel YB. Stein EA, et al. Among authors: bays h. Am J Cardiol. 1998 Aug 1;82(3):311-6. doi: 10.1016/s0002-9149(98)00421-4. Am J Cardiol. 1998. PMID: 9708659 Clinical Trial.

2

Drug treatment of dyslipidemias: practical guidelines for the primary care physician.

Bays HE, Dujovne CA, Lansing AM. Bays HE, et al. Heart Dis Stroke. 1992 Nov-Dec;1(6):357-65. Heart Dis Stroke. 1992. PMID: 1344132 No abstract available.

3

Drug therapy for hyperlipidemia. When reducing cardiovascular risk is a priority.

Bays HE, Dujovne CA. Bays HE, et al. Postgrad Med. 1992 Apr;91(5):162-4, 167-8, 171-2 passim. doi: 10.1080/00325481.1992.11701287. Postgrad Med. 1992. PMID: 1561158 Review.

4

Drugs for treatment of patients with high cholesterol blood levels and other dyslipidemias.

Bays HE, Dujovne CA. Bays HE, et al. Prog Drug Res. 1994;43:9-41. doi: 10.1007/978-3-0348-7156-3_2. Prog Drug Res. 1994. PMID: 7855253 Review. No abstract available.

5

Elevated lipoprotein (a) blood levels as the single treatable atherosclerotic risk factor in patients with coronary artery disease.

Bays H, Dujovne CA, Mays JB. Bays H, et al. J Ky Med Assoc. 1993 Nov;91(11):498-500. J Ky Med Assoc. 1993. PMID: 8270845

6

Drug interactions of lipid-altering drugs.

Bays HE, Dujovne CA. Bays HE, et al. Drug Saf. 1998 Nov;19(5):355-71. doi: 10.2165/00002018-199819050-00003. Drug Saf. 1998. PMID: 9825949 Review.

7

Lipid-altering drugs in development.

Bays HE, Dujovne CA. Bays HE, et al. Drugs R D. 1999 Jun;1(6):463-9. doi: 10.2165/00126839-199901060-00010. Drugs R D. 1999. PMID: 10566085 Review.

8

A Multicenter, Placebo-Controlled, Dose-Ranging Study of Atorvastatin.

Schrott H, Fereshetian AG, Knopp RH, Bays H, Jones PH, Littlejohn TW 3rd, McLain R, Black DM. Schrott H, et al. Among authors: bays h. J Cardiovasc Pharmacol Ther. 1998 Apr;3(2):119-124. doi: 10.1177/107424849800300204. J Cardiovasc Pharmacol Ther. 1998. PMID: 10684489

9

Effects of simvastatin (40 and 80 mg/day) in patients with mixed hyperlipidemia.

Stein E, Plotkin D, Bays H, Davidson M, Dujovne C, Korenman S, Stepanavage M, Mercuri M. Stein E, et al. Among authors: bays h. Am J Cardiol. 2000 Aug 15;86(4):406-11. doi: 10.1016/s0002-9149(00)00955-3. Am J Cardiol. 2000. PMID: 10946033 Clinical Trial.

10

Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.

Dobs AS, Schrott H, Davidson MH, Bays H, Stein EA, Kush D, Wu M, Mitchel Y, Illingworth RD. Dobs AS, et al. Among authors: bays h. Metabolism. 2000 Sep;49(9):1234-8. doi: 10.1053/meta.2000.7716a. Metabolism. 2000. PMID: 11016911 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters